The U.S. Department of Health and Human Services (HHS), under the leadership of Secretary Robert F. Kennedy, Jr., has announced a comprehensive package of initiatives aimed at strengthening the nation’s response to Lyme disease and other tick-borne illnesses. Unveiled during a press conference in New Hampshire one of the states most significantly affected by Lyme disease the measures represent a renewed federal commitment to addressing the growing public health burden posed by tick-borne infections across the United States.
As part of the initiative, HHS will launch a multi-million-dollar pilot program focused on innovative tick control strategies designed to reduce human exposure to disease-carrying ticks. The department is also introducing up to $2.5 million in innovation challenges to encourage researchers, entrepreneurs, and public health experts to develop new tools, technologies, and approaches for the prevention, detection, and management of tick-borne diseases. These challenges are expected to foster groundbreaking solutions that can improve public health outcomes and strengthen community resilience in high-risk regions.
In addition, the National Institutes of Health (NIH) will provide funding to researchers investigating Alpha-gal syndrome, a serious allergic condition linked to tick bites that can cause potentially life-threatening reactions to red meat and other mammalian products. Increased investment in Alpha-gal syndrome research aims to improve understanding of the condition, advance diagnostic capabilities, and support the development of effective treatments for affected patients.
Recognizing the challenges many patients face in obtaining timely and accurate care, HHS is also facilitating a public-private collaboration to help individuals connect with healthcare providers experienced in diagnosing and treating Lyme disease and other tick-borne illnesses. The initiative seeks to improve access to specialized care, reduce delays in diagnosis, and ensure that patients receive evidence-based treatment and support throughout their healthcare journey.
Secretary Kennedy announced these initiatives following a roundtable discussion with state lawmakers, healthcare professionals, patient advocates, and members of the Lyme disease community during his “Take Back Your Health” tour. The discussions highlighted the urgent need for greater awareness, stronger prevention measures, enhanced research efforts, and improved healthcare resources to address the increasing prevalence of tick-borne diseases nationwide.
Lyme disease remains the most commonly reported vector-borne disease in the United States, with cases continuing to rise in many regions due to expanding tick populations, environmental changes, and increased human exposure to tick habitats. Other tick-borne illnesses, including babesiosis, anaplasmosis, ehrlichiosis, Rocky Mountain spotted fever, and Alpha-gal syndrome, have also become growing public health concerns, underscoring the need for a coordinated and proactive national response.
The newly announced HHS initiatives reflect a broader strategy to bring together federal agencies, scientific institutions, healthcare providers, industry partners, and community stakeholders to accelerate innovation and improve disease prevention and treatment. By investing in research, supporting public health interventions, and expanding patient access to specialized care, HHS aims to reduce the impact of tick-borne diseases on individuals, families, and communities across the country.
Through these efforts, the department hopes to strengthen surveillance and prevention programs, encourage scientific breakthroughs, and raise public awareness about the importance of early detection and tick-bite prevention. The initiatives mark a significant step toward addressing one of the nation’s fastest-growing infectious disease threats and improving health outcomes for millions of Americans at risk of Lyme disease and other tick-borne illnesses.
Also Read: DRC and WHO Issue Joint Statement on Bundibugyo Ebola Outbreak
These efforts reflect a growing national focus on combating the rising incidence of tick-borne diseases, improving patient outcomes, advancing research into emerging health threats, and strengthening public awareness and prevention strategies. By bringing together government agencies, researchers, healthcare professionals, and community stakeholders, HHS aims to accelerate innovation and deliver more effective solutions for individuals and families affected by Lyme disease and other tick-related illnesses.
